Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating activities:
Net loss	$ (15,266)	$ (5,519)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	536	226
Reserve for inventory obsolescence	410
Change in fair value of preferred stock warrant and contingent shares liability	3,120	8
Change in fair value of derivative liability	38,251
Deferred tax benefit	(11,147)
Non-cash interest expense	982	150
Stock-based compensation	863	52
Allowance for credit losses	170	58
Loss on debt extinguishment	171	3,613
Non-cash lease expense	415
Accretion of interest on marketable securities	(204)
Changes in operating assets and liabilities:
Accounts receivable	(30,057)	(5,100)
Inventory	(26,134)	323
Prepaid expenses and other assets	167	(1,017)
Accounts payable	30,254	(77)
Accrued expenses and other liabilities	2,267	743
Deferred revenue	(500)	(10)
Warranty liability	1,142	269
Deferred rent		(135)
Operating lease liabilities	(374)
Net cash used in operating activities	(4,934)	(6,416)
Investing activities:
Purchase of marketable securities	(50,221)
Acquisition of fSight	(16)
Purchase of intangible assets	(450)
Purchase of property and equipment	(1,510)	(308)
Disposals of property and equipment	73
Net cash used in investing activities	(52,124)	(308)
Financing activities:
Proceeds from Convertible Promissory Note	50,000
(Repayment of) proceeds from Series 2022-1 Notes	(20,833)	25,000
Repayment of Senior Bonds		(10,000)
Payment of financing costs	(354)	(3,483)
Proceeds from sale of Series E convertible preferred stock		21,845
Proceeds from Business Combination	2,238
Proceeds from exercise of stock options	106	23
Payment of tax withholdings on stock options	(91)
Net cash provided by financing activities	31,066	33,385
Net (decrease) increase in cash and restricted cash	(25,992)	26,661
Cash, cash equivalents, and restricted cash at beginning of period	37,717	7,474
Cash, cash equivalents, and restricted cash at end of period	11,725	34,135
Supplemental disclosure of cash flow information:
Cash paid for interest	168	699
Cash paid for income taxes	53	22
Supplemental schedule of non-cash investing and financing activities:
Financing costs in accounts payable and accrued expenses		122
Net assets acquired from ROCG	573
Operating lease right of use assets obtained in exchange for operating lease liabilities	1,973
Property plant and equipment in accounts payable	297	$ 48
Non-cash consideration paid for the acquisition of fSight	10,974
Contingent shares liability from fSight acquisition	2,167
Fair value of derivative note liability at issuance	23,525
Convertible preferred stock dividends (Note 3)	12,581
Reclassification of deferred issuance costs to additional paid in capital	2,221
Conversion of convertible preferred stock into common stock in connection with the Business Combination (Note 3)	87,140
Issuance of preferred stock upon exercise of preferred warrants	2,008
Unrealized loss resulting from change in fair value of marketable securities	$ (181)